Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: a case report

BMC Med Genet. 2020 Oct 12;21(1):200. doi: 10.1186/s12881-020-01137-4.

Abstract

Background: Dedifferentiated liposarcoma (DDLPS), which accounts for an estimated 15-20% of liposarcomas, is a high-grade and aggressive malignant neoplasm, exhibiting a poor response to available therapeutic agents. However, genetic alteration profiles of DDLPS as well as the role of NF1 mutations have not been studied extensively.

Case presentation: The current study reports a patient presenting with rapidly growing DDLPS accompanied by multiple lung and pleural metastases, in whom whole-exome sequencing revealed a NF1 truncating mutation of the known pathogenic variant, c.C7486T, p.R2496X, as well as multiple copy number alterations (CNAs), including the well-known 12q13-15 amplification, and multiple chromothripsis events encompassing potential cancer-related genes.

Conclusions: Our results suggest that, in addition to the 12q13-15 amplification, NF1 inactivation mutation and other CNAs may contribute to DDLPS tumorigenesis accompanied by aggressive clinical features.

Keywords: Case report; Copy number alteration; Copy number alternation; Liposarcoma; Mutation; NF1.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • DNA Copy Number Variations*
  • Exome Sequencing / methods
  • Fatal Outcome
  • Humans
  • Liposarcoma / genetics*
  • Liposarcoma / pathology
  • Liposarcoma / surgery
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / secondary
  • Male
  • Mutation*
  • Neurofibromin 1 / genetics*

Substances

  • NF1 protein, human
  • Neurofibromin 1